Welcome to our dedicated page for SkinHealth Systems SEC filings (Ticker: SKIN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
SkinHealth Systems Inc. filings document the regulatory record for a Nasdaq-listed medical aesthetics company formerly known as The Beauty Health Company. The filings identify its Class A common stock, operating and financial results, non-GAAP reconciliations, and material-event disclosures tied to quarterly and annual reporting.
Its SEC record also includes proxy materials for annual stockholder voting, board and committee governance, director appointments, officer departures, compensatory arrangements, capital-structure disclosures and shareholder voting matters. These filings provide the formal disclosure framework for the company behind Hydrafacial, SkinStylus and related professional skin-health offerings.
Mirabella Financial Services LLP reported beneficial ownership of 12,790,383 shares of Beauty Health Company (common stock), representing 10.21% of the class. The filing states these shares are held on behalf of Blue Riband Fund LP, for which Mirabella acts as investment manager and has sole voting and dispositive power over the reported shares. The filing notes the holdings were acquired in the ordinary course of business and not for the purpose of changing or influencing control. The issuer's principal executive office is listed in Long Beach, California.
The Beauty Health Company (SKIN) filed a Current Report on Form 8-K reporting a material event dated September 4, 2025. The filing incorporates by reference a Supplemental Indenture No. 1 dated September 4, 2025 among The Beauty Health Company, the guarantors party thereto and U.S. Bank Trust Company, National Association, acting as trustee and collateral agent. The document includes an exhibit list and an embedded Inline XBRL cover page data file. The report is signed by Michael Monahan, Chief Financial Officer.
Janus Henderson Group plc reports beneficial ownership of 5,718,565 shares of The Beauty Health Company, representing 4.5% of the class. The filing indicates shared voting and shared dispositive power over those shares while noting no sole voting or dispositive power. The reporting person is organized in Jersey and identified as an investment adviser/holding company (IA, HC). The statement also discloses that indirect subsidiaries (JHIUS, JHIUKL and JHIAIFML) act as registered investment advisers providing advice to Managed Portfolios.
The Beauty Health Company (SKIN) Form 4 reports a non-sale withholding of shares by Chief Financial Officer Michael P. Monahan related to the vesting of restricted stock units. On 08/10/2025, 32,357 shares were withheld to satisfy tax withholding at a recorded price of $1.89 per share. The disclosure states this withholding "does not represent a sale." Following the transaction, the reporting person’s beneficial ownership is shown as 1,326,305 shares.
This filing documents an internal compensation settlement (tax withholding on vested RSUs) rather than an open-market transaction, and it clarifies the officer’s post-transaction share count.
Form 4 Overview – The Beauty Health Company (SKIN)
Director Desiree Gruber filed a Form 4 reporting the award of 73,051 Class A common-stock RSUs on 16 June 2025. The award was coded “A” (acquired) and represents equity compensation rather than an open-market purchase. After this grant, Gruber’s total beneficial ownership rises to 192,565 shares, all held directly.
Vesting Terms
- The RSUs vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the 2026 annual meeting of shareholders.
- Continuous board service is required through the vesting date.
Key Takeaways for Investors
- The filing signals continued board-level alignment with shareholders, although the grant is part of the regular director compensation program rather than a discretionary purchase.
- No derivative securities transactions were reported, and no shares were disposed of.
- The transaction does not alter the company’s cash position or share count today, but it will have a modest dilutive effect upon vesting.
Form 4 filing for The Beauty Health Company (SKIN) discloses that director Michelle C. Kerrick was granted 73,051 restricted stock units (RSUs) on 06/16/2025 (Transaction Code A).
• The RSUs vest on the earlier of the one-year anniversary of the grant or the date of the company’s 2026 annual shareholders’ meeting, subject to her continued board service.
• After the grant, Kerrick’s total beneficial ownership increases to 189,813 Class A shares, held directly.
• No derivative securities were involved and no shares were sold.
The filing represents routine director equity compensation and does not indicate any open-market buying or selling activity.